Cardiac Disease
Conditions
Keywords
cerebral autoregulation, cardiopulmonary bypass, stroke
Brief summary
The aims of this study are: i) to assess cerebral autoregulation and autonomic control within the different phases of cardiac surgery with cardiopulmonary bypass; ii) to compare cerebral autoregulation measures derived via cerebral blood flow velocity estimated by transcranial Doppler device with simpler measurements derived from near infrared spectroscopy; iii) to develop a predictive model of postoperative cerebrovascular outcome (overt or silent stroke) based on the extracted indices.
Interventions
Perioperative characterization of cerebral autoregulation and autonomic function; characterization of adverse events after surgery
Sponsors
Study design
Eligibility
Inclusion criteria
* age older than 18 years * spontaneous sinus rhythm * no pregnancy * signed informed consent
Exclusion criteria
* age lower than 18 years * absence of sinus rhythm * autonomic disorders * concomitant carotid intervention * reintervention * contraindication to MRI * pregnancy * impossibility of informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Autoregulation index (ARI) | 36 months | ARI is an index describing the state of cerebral autoregulation from mean cerebral blood velocity and mean arterial pressure. It ranges between 1 and 9. ARI\>4 means working autoregulation. ARI\<4 means impaired autoregulation. It will be computed for all participants in BASAL, ANESTH, CPB. |
| Cerebral Oxymetry index (CoX) | 36 months | CoX is an index describing the state of cerebral autoregulation derived from NIRS and mean arterial pressure. It ranges between 0 and 1. CoX = 1 means perfect coupling. Cox=0 means uncoupling. It will be computed for all participants in BASAL, ANESTH, CPBasurements derived from near infrared spectroscopy |
| number of patients developing cerebrovascular adverse events | 36 months | The number of patients developing cerebrovascular adverse events will be assessed by the presence of positive lesions as detected by DW-MRI. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Baroreflex sensitivity | 36 months | Baroreflex sensitivity will be measured in ms/mmHg. A higher value means a better baroreflex regulation. It will be computed in all participants during BASAL, ANESTH, CPB. |
Countries
Italy